Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKommentar/debatForskningpeer review

  • Rhys Whomsley, European Medicines Agency
  • ,
  • Susanne Brendler-Schwaab, Federal Institute for Drugs and Medical Devices (BfArM)
  • ,
  • Eadaoin Griffin, Health Products Regulatory Authority
  • ,
  • John Jensen
  • Caroline Moermond, National Institute for Public Health and the Environment (RIVM), Bilthoven
  • ,
  • Birger Scholz, Swedish Medical Products Agency
  • ,
  • Laila Sortvik Nilssen, The Norwegian Medicines Agency (NOMA)
  • ,
  • Henry Stemplewski, Medicines & Healthcare Products Regulatory Agency (MHRA)
  • ,
  • Ines Roennefahrt, German Environment Agency
OriginalsprogEngelsk
Artikelnummer17
TidsskriftEnvironmental Sciences Europe
Vol/bind31
Nummer1
Antal sider4
ISSN2190-4707
DOI
StatusUdgivet - 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 148203725